Furthermore, Sult2b1−/− mice exhibited markedly increased counts and areas of SI ulcers, compared with those in Sult2b1+/+ mice, and these ulcerative lesions were dramatically ameliorated by CS administration (Figures 6C, D). This evidence concerns the gene SULT2B1 and ulcer disease.